reglab/statecodes huggingface dataset:
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 22 - Child Abuse Medical Providers › Section 13-2207 - Children's Trust Fund

(a)    In this section, “Fund” means the Children’s Trust Fund.
(b)    There is a Children’s Trust Fund.
(c)    The purpose of the Fund is to provide funding for the Child Abuse Medical Providers (Maryland CHAMP) Initiative.
(d)    The Department shall administer the Fund.
(e)    The Fund is a special, nonlapsing fund that is not subject to § 7-302 of the State Finance and Procurement Article.
(f)    The Fund consists of:
(1)    Fees distributed to the Fund from the issuance of commemorative birth certificates under § 4-217(a)(3) of this article;
(2)    Money appropriated in the State budget to the Fund; and
(3)    Any other money from any other source accepted for the benefit of the Fund.
(g)    The Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(h)    The Treasurer shall invest and reinvest the money of the Fund in the same manner as other State money may be invested.
(i)    (1)    The Comptroller shall pay out money from the Fund as directed by the Secretary.
(2)    No part of the Fund may revert or be credited to:
(i)    The General Fund of the State; or
(ii)    Any other special fund of the State.
(j)    Expenditures from the Fund may be made only in accordance with the State budget.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 23 - Folic Acid Supplement Distribution Program › Section 13-2301 - "Women of Childbearing Age" Defined

In this subtitle, “women of childbearing age” means women between the ages of 15 and 45 years old who have family incomes at or below 185% of the federal poverty level.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 23 - Folic Acid Supplement Distribution Program › Section 13-2302 - General Consideration

(a)    The Department shall establish a program to distribute a folic acid supplement to women of childbearing age.
(b)    The purpose of the program is to reduce the number of cases of neural tube defects in the State.
(c)    The program shall provide the following to women of childbearing age as appropriate, based on an assessment of their individual need:
(1)    An appropriate folic acid supplement that contains the recommended level of folic acid for women of childbearing age;
(2)    Counseling and written information regarding the proper use of the supplement; and
(3)    Any other health information that the Department determines necessary to carry out the purposes of this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 25 - Oral Health Safety Net Program › Section 13-2501 - Oral Health Safety Net Program

(a)    In this subtitle, “Program” means the Oral Health Safety Net Program.
(b)    There is an Oral Health Safety Net Program in the Office of Oral Health in the Department.
(c)    The purpose of the Program is to provide start–up funding to expand oral health capacity for underserved low–income and disabled individuals, including individuals enrolled in the Maryland Medical Assistance Program and in the Maryland Children’s Health Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 25 - Oral Health Safety Net Program › Section 13-2502 - Grants

(a)    The Office of Oral Health shall solicit proposals from local health departments, federally qualified health centers, and entities providing dental services within State facilities, for the purpose of issuing grants to support collaborative and innovative ways to increase dental provider capacity for the underserved.
(b)    Subject to the limitations of the State budget, the Office of Oral Health shall:
(1)    Award grants; and
(2)    Oversee the operation of the Program.
(c)    The Office of Oral Health shall place priority on awarding grants to proposals that:
(1)    Are targeted to regions of the State where oral health services are most scarce for low–income, disabled, and Medicaid populations; and
(2)    Outline how the potential grantee will maximize limited resources, including:
(i)    Sharing of resources with other persons;
(ii)    Case management to eliminate barriers to dental services;
(iii)    Public–private purchasing agreements;
(iv)    Obtaining matching funds to increase resources;
(v)    Incentives to increase provider participation;
(vi)    Quantifiable outcome measures of success;
(vii)    School–based screenings; and
(viii)    Plans to ensure sustainability of services after termination of grants awarded under this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 25 - Oral Health Safety Net Program › Section 13-2503 - Additional Functions

Subject to the limitations of the State budget, the Office of Oral Health shall:
(1)    Contract with a licensed dentist to provide expertise in dental public health issues for the Office; and
(2)    Provide for appropriate continuing education courses for providers that offer oral health treatment to underserved populations.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 25 - Oral Health Safety Net Program › Section 13-2504 - Annual Evaluation

(a)    (1)    The Office of Oral Health shall conduct an annual evaluation of the Program.
(2)    The evaluation required under this subsection shall include:
(i)    Data on any progress resulting from each grant awarded under this subtitle;
(ii)    Data on any progress of the overall Program;
(iii)    Data demonstrating any increase in the use of restorative dental care among underserved populations; and
(iv)    Data from any statewide survey conducted by the Department that demonstrates any progress of the Program.
(b)    The Department, in conjunction with the Office of Oral Health, shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on or before November 1 of each year on:
(1)    The results of the Program;
(2)    Findings and recommendations for the Oral Health Program and any other oral health programs established under Title 18, Subtitle 8 of this article;
(3)    The availability and accessibility of dentists throughout the State participating in the Maryland Medical Assistance Program;
(4)    The outcomes that managed care organizations and dental managed care organizations under the Maryland Medical Assistance Program achieve concerning the utilization of targets required by the Five Year Oral Health Care Plan, including:
(i)    Loss ratios that the managed care organizations and dental managed care organizations experience for providing dental services; and
(ii)    Corrective action by managed care organizations and dental managed care organizations to achieve the utilization targets; and
(5)    The allocation and use of funds authorized for dental services under the Maryland Medical Assistance Program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 25 - Oral Health Safety Net Program › Section 13-2505 - Legislative Intent

It is the intent of the General Assembly:
(1)    That grants shall be awarded through the Program from July 1, 2008 through June 30, 2009, for fiscal year 2009; and
(2)    That full funding for grants shall continue in the subsequent two fiscal years unless the Office of Oral Health determines that a grantee is not fulfilling the conditions of the award.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 27 - Behavioral Health Services for Maryland Veterans › Section 13-2701 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Behavioral health services” means mental health services or alcohol and substance abuse services.
(c)    (1)    “Crisis services” means temporary services designed to address and stabilize a severe behavioral health problem and to avoid an emergency situation.
(2)    “Crisis services” includes hotlines, in–home support, and residential crisis services.
(d)    “Maryland Defense Force” means the military force established under § 13–501 of the Public Safety Article.
(e)    “Maryland National Guard” means the Maryland Army National Guard and Maryland Air National Guard.
(f)    “Service coordination” means a service designed to coordinate and provide assistance in obtaining access to behavioral health services.
(g)    “Uniformed services” has the meaning stated in 10 U.S.C. § 101.
(h)    “Veteran” means a Maryland resident who served on active duty in the uniformed services of the United States, other than for training, and was discharged or released under conditions other than dishonorable.
(i)    “Web–based resource program” means an interactive web–based communication medium that:
(1)    Allows individuals to access comprehensive information, advocacy, and other resources regarding public and private behavioral health services, crisis and emergency services, and early intervention and prevention programs; and
(2)    Enables the public and private health care communities to work together to address the problems related to providing and obtaining access to behavioral health services.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 27 - Behavioral Health Services for Maryland Veterans › Section 13-2703 - Mental Health First Aid -- Training -- Reports of Training

(a)    The behavioral health services for which the Department provides service coordination for veterans under this subtitle shall include mental health first aid.
(b)    Mental health first aid shall consist of training for veterans and the immediate family members of veterans on how to identify and respond to signs of mental illness and substance use disorders.
(c)    Each entity teaching a mental health first aid course shall report to the Department:
(1)    The number of veterans who took the mental health first aid course; and
(2)    The number of family members of veterans who took the mental health first aid course.
(d)    On or before June 1 each year, beginning in 2023, if the Department received a report under subsection (c) of this section in the immediately preceding year, the Department shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly the following information for the immediately preceding year:
(1)    The total number of veterans in the State who took a mental health first aid course;
(2)    The total number of family members of veterans in the State who took a mental health first aid course; and
(3)    The total number of mental health first aid courses taught in the State, reported by the entity that taught the mental health first aid course.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 30 - Cord Blood Transplant Program › Section 13-3001 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Cord blood transplant center” means a medical facility that uses cells obtained from a human umbilical cord or placenta to treat pediatric or adult patients afflicted with a disease or injury.
(c)    “Fund” means the Cord Blood Transplant Center Support Fund.
(d)    “Qualified medical institution” means a medical institution accredited by the Joint Commission on Accreditation of Health Care Organizations that:
(1)    Is located in the State; and
(2)    Has an established hematologic malignancies research program.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 30 - Cord Blood Transplant Program › Section 13-3002 - Program

(a)    There is a Cord Blood Transplant Program in the Department.
(b)    The purpose of the Cord Blood Transplant Program is to provide funding, subject to the limitations of the State budget, to qualified medical institutions to establish or maintain a cord blood transplant center.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 30 - Cord Blood Transplant Program › Section 13-3003 - Fund

(a)    There is a Cord Blood Transplant Center Support Fund.
(b)    The purpose of the Fund is to promote economic development by supporting cord blood transplant centers at qualified medical institutions with a goal of being recognized as a regional center of excellence in the area of cord blood transplantation.
(c)    The Department shall administer the Fund.
(d)    The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(e)    The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(f)    The Fund consists of:
(1)    Beginning in 2013, any money appropriated in the State budget to the Fund; and
(2)    Any other money from any other source accepted for the benefit of the Fund.
(g)    The Fund may be used only for the establishment of or support for a cord blood transplant center at a qualified medical institution.
(h)    (1)    The State Treasurer shall invest and reinvest the money of the Fund in the same manner as other State money may be invested.
(2)    Any investment earnings of the Fund shall be paid into the Fund.
(i)    (1)    The Comptroller shall pay out money from the Fund as directed by the Secretary.
(2)    No part of the Fund may revert or be credited to:
(i)    The General Fund of the State; or
(ii)    Any other special fund of the State.
(j)    Expenditures from the Fund may be made only in accordance with the State budget.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3101 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Pharmacist” has the meaning stated in § 12–101 of the Health Occupations Article.
(c)    “Private or public entity” means a health care provider, local health department, community–based organization, substance abuse treatment organization, or other person that addresses medical or social issues related to drug addiction.
(d)    “Program” means the Overdose Response Program.
(e)    “Standing order” means a written instruction for the prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food and Drug Administration in accordance with § 13–3106 of this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3102 - Purpose

The Overdose Response Program is a program administered by the Department for the purpose of providing a means of authorizing certain individuals to administer an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual experiencing, or believed to be experiencing, opioid overdose to help prevent a fatality when medical services are not immediately available.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3103 - Powers and Duties of Department

(a)    The Department shall adopt regulations necessary for the administration of the Program.
(b)    The Department may:
(1)    Collect fees necessary for the administration of the Program;
(2)    Authorize private or public entities to conduct education and training on opioid overdose recognition and response that include:
(i)    Education on recognizing the signs and symptoms of an opioid overdose;
(ii)    Training on responding to an opioid overdose, including the administration of opioid overdose reversal drugs approved by the federal Food and Drug Administration; and
(iii)    Access to opioid overdose reversal drugs approved by the federal Food and Drug Administration and the necessary supplies for the administration of the opioid overdose reversal drugs;
(3)    Develop guidance regarding the content of educational training programs conducted by private or public entities; and
(4)    Collect and report data on the operation and results of the programs.
(c)    An individual is not required to obtain training and education on opioid overdose recognition and response from a private or public entity under subsection (b) of this section in order for a pharmacist to dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to the individual.
(d)    (1)    Subject to the limitations of the State budget, the Department shall purchase and provide opioid overdose reversal drugs approved by the federal Food and Drug Administration, at no cost, to the providers who are required to offer opioid overdose reversal drugs approved by the federal Food and Drug Administration under § 8–408 or § 19–310.3 of this article.
(2)    An entity required to offer an opioid overdose reversal drug approved by the federal Food and Drug Administration under § 8–408 or § 19–310.3 of this article may provide an opioid overdose reversal drug approved by the federal Food and Drug Administration only if the opioid overdose reversal drug approved by the federal Food and Drug Administration is provided by the Department.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3104 - Written Agreements to Establish Dispensing Protocols

An authorized private or public entity shall enter into a written agreement with a licensed health care provider with prescribing authority to establish protocols for the prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food and Drug Administration to any individual in accordance with this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3105 - Naloxone Prescription -- Possession and Use by Individuals

(a)    An individual may receive from any licensed health care provider with prescribing authority a prescription for an opioid overdose reversal drug approved by the federal Food and Drug Administration and the necessary supplies for the administration of the opioid overdose reversal drug.
(b)    An individual for whom an opioid overdose reversal drug approved by the federal Food and Drug Administration is prescribed and dispensed in accordance with this subtitle may:
(1)    Possess the prescribed opioid overdose reversal drug and the necessary supplies for the administration of the opioid overdose reversal drug; and
(2)    In an emergency situation when medical services are not immediately available, administer the opioid overdose reversal drug to an individual experiencing or believed by the individual to be experiencing an opioid overdose.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3106 - Prescribing and Dispensing Naloxone

(a)    A licensed health care provider with prescribing authority may prescribe and dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who:
(1)    Is believed by the licensed health care provider to be at risk of experiencing an opioid overdose; or
(2)    Is in a position to assist an individual at risk of experiencing an opioid overdose.
(b)    (1)    A licensed health care provider with prescribing authority may prescribe and dispense opioid overdose reversal drugs approved by the federal Food and Drug Administration by issuing a standing order if the licensed health care provider:
(i)    Is employed by the Department or a local health department; or
(ii)    Has a written agreement with an authorized private or public entity under § 13–3104 of this subtitle.
(2)    A licensed health care provider with prescribing authority who issues a standing order under paragraph (1) of this subsection may delegate the dispensing of opioid overdose reversal drugs approved by the federal Food and Drug Administration to an employee or a volunteer of an authorized private or public entity in accordance with a written agreement under § 13–3104 of this subtitle.
(3)    Any licensed health care provider who has dispensing authority also may dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to any individual in accordance with a standing order issued by a licensed health care provider with prescribing authority in accordance with this subsection.
(c)    A pharmacist may dispense opioid overdose reversal drugs approved by the federal Food and Drug Administration in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3107 - Immunity -- Not Deemed to Be Practicing Medicine, Registered Nursing, or Pharmacy

(a)    An individual who, in accordance with this subtitle, is administering an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual experiencing or believed by the individual to be experiencing an opioid overdose may not be considered to be practicing:
(1)    Medicine for the purposes of Title 14 of the Health Occupations Article; or
(2)    Registered nursing for the purposes of Title 8 of the Health Occupations Article.
(b)    An employee or volunteer of a private or public entity who, in accordance with this subtitle, provides an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who has received education and training in opioid overdose recognition and response in accordance with a standing order may not be considered to be practicing:
(1)    Medicine for the purposes of Title 14 of the Health Occupations Article;
(2)    Registered nursing for the purposes of Title 8 of the Health Occupations Article; or
(3)    Pharmacy for the purposes of Title 12 of the Health Occupations Article.
(c)    A licensed health care provider who prescribes or dispenses opioid overdose reversal drugs approved by the federal Food and Drug Administration in accordance with this subtitle may not be subject to any disciplinary action by the appropriate licensing health occupations board under the Health Occupations Article solely for the act of prescribing or dispensing opioid overdose reversal drugs approved by the federal Food and Drug Administration.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 31 - Overdose Response Program › Section 13-3108 - Immunity -- Individuals and Medical Providers

(a)    An individual who administers an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who is or in good faith is believed to be experiencing an opioid overdose shall have immunity from liability under §§ 5–603 and 5–629 of the Courts Article.
(b)    A cause of action may not arise against any licensed health care provider with prescribing authority or pharmacist for any act or omission when the health care provider with prescribing authority or pharmacist in good faith prescribes or dispenses an opioid overdose reversal drug approved by the federal Food and Drug Administration and the necessary paraphernalia for the administration of the opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual under § 13–3106 of this subtitle.
(c)    A cause of action may not arise against any business or business owner for any act or omission when the business or business owner in good faith makes opioid overdose reversal drugs approved by the federal Food and Drug Administration available to the employees or patrons of the business along with the necessary paraphernalia for administration of the opioid overdose reversal drugs approved by the federal Food and Drug Administration to an individual under § 13–3104 or § 13–3106 of this subtitle.
(d)    This subtitle may not be construed to create a duty on any individual to:
(1)    Obtain education and training from an authorized private or public entity under this subtitle, and an individual may not be held civilly liable for failing to obtain education and training from an authorized private or public entity under this subtitle; or
(2)    Administer opioid overdose reversal drugs approved by the federal Food and Drug Administration to an individual who is experiencing or believed by the individual to be experiencing an opioid overdose.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3201 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Council” means the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council.
(c)    “Director” means the Director of Dementia Services and Brain Health established under Subtitle 32A of this title.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3203 - Membership

(a)    The Council consists of the following members:
(1)    One member of the Senate of Maryland, appointed by the President of the Senate;
(2)    One member of the House of Delegates, appointed by the Speaker of the House;
(3)    The Secretary of Health, or the Secretary’s designee;
(4)    The Secretary of Aging, or the Secretary’s designee;
(5)    The Executive Director of the Alzheimer’s Association, Greater Maryland Chapter, or the Executive Director’s designee;
(6)    The President of the Alzheimer’s Association, National Capital Area Chapter, or the President’s designee; and
(7)    The following members, appointed by the Governor:
(i)    Seven health care professionals with relevant professional experience;
(ii)    Three human service professionals with relevant professional experience;
(iii)    One elder law attorney with relevant professional experience;
(iv)    Two research professionals with relevant professional experience;
(v)    Two family caregivers of individuals with Alzheimer’s disease or a related disorder; and
(vi)    At the recommendation of the Council, any other member necessary to fulfill the duties of the Council.
(b)    To the extent practicable, the members appointed to the Council shall reflect the geographic, racial, ethnic, cultural, and gender diversity of the State.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3204 - Chair; Compensation; Reimbursement for Expenses

(a)    The members of the Council shall select the chair of the Council.
(b)    A member of the Council:
(1)    May not receive compensation as a member of the Council; but
(2)    Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(c)    (1)    The term of an appointed member of the Council is 3 years.
(2)    The terms of the appointed members of the Council are staggered as required by the terms provided for the appointed members of the Council on October 1, 2022.
(3)    At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.
(4)    A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3205 - Staff

(a)    The Director, with assistance from the Department of Aging, shall provide staff support for the Council.
(b)    The Director may request staffing assistance from public health entities with an interest in the duties of the Council.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3206 - Duties

The Council shall:
(1)    Update the State Plan on Alzheimer’s Disease and Related Dementias and advocate for the State Plan;
(2)    (i)    Examine the needs of individuals with Alzheimer’s disease and related dementias and their caregivers; and
(ii)    Identify methods through which the State can most effectively and efficiently assist in meeting those needs;
(3)    Advise the Governor and the General Assembly on policy, funding, regulatory, and other issues related to individuals with Alzheimer’s disease and related dementias and their caregivers; and
(4)    Develop and promote strategies to encourage brain health and reduce cognitive decline.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32 - Virginia I. Jones Alzheimer's Disease and Related Dementias Council › Section 13-3207 - Report

On or before September 1, 2022, and on or before September 1 every 5 years thereafter, the Council shall issue and publish an update to the State Plan on Alzheimer’s Disease and Related Dementias.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32A - Director of Dementia Services and Brain Health › Section 13-32A-01 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
(b)    “Council” means the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council.
(c)    “Director” means the Director of Dementia Services and Brain Health.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32A - Director of Dementia Services and Brain Health › Section 13-32A-04 - Purpose of Director Position -- Duties

(a)    The purpose of the position of Director is to coordinate and facilitate communication relating to dementia services in the State.
(b)    The Director shall:
(1)    Coordinate the Department’s approach to addressing Alzheimer’s disease and other forms of dementia and brain health, including through public awareness, prevention, and early detection and diagnosis;
(2)    Staff the Council and oversee implementation of the State Plan on Alzheimer’s Disease and Related Dementias;
(3)    Assess, analyze, and conduct outreach to share cognitive health and dementia–related data;
(4)    Develop and monitor implementation milestones and measurable outcomes to assess progress in achieving the goals laid out in the State Plan on Alzheimer’s Disease and Related Dementias;
(5)    Identify efficiencies across State agencies that aid individuals with dementia and their caregivers, and coordinate public and private stakeholder partnerships;
(6)    Apply for grants to enable the implementation of the State Plan on Alzheimer’s Disease and Related Dementias goals to reduce the risk of dementia, and to improve the quality of care for individuals with dementia and their caregivers; and
(7)    Carry out other duties relevant to the support of individuals with dementia as may be assigned by the Department.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32A - Director of Dementia Services and Brain Health › Section 13-32A-05 - Recurring Reports by Director on Activities and Recommendations

On or before September 1, 2023, and on or before September 1 every 5 years thereafter, the Director shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee and the House Health and Government Operations Committee on the activities and recommendations of the Director.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 32A - Director of Dementia Services and Brain Health › Section 13-32A-06 - Annual Appropriations

The Governor shall include in the annual budget bill an appropriation to fund the position of Director and the Council, as follows:
(1)    For fiscal year 2023, at least $71,400;
(2)    For fiscal year 2024, at least $83,000;
(3)    For fiscal year 2025, at least $85,300;
(4)    For fiscal year 2026, at least $87,600; and
(5)    For fiscal year 2027 and each fiscal year thereafter, at least $89,900.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3301.1 - Legislative Intent.

The General Assembly intends that the programs implemented in accordance with this subtitle yield a successful but consumer–friendly medical cannabis industry in the State to provide patients affordable and adequate access to medical cannabis.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3303.1 - Compassionate Use Fund.

(a)    In this section, “Compassionate Use Fund” means the Natalie M. LaPrade Medical Cannabis Compassionate Use Fund.
(b)    There is a Natalie M. LaPrade Medical Cannabis Compassionate Use Fund.
(c)    (1)    The Commission shall:
(i)    Administer the Compassionate Use Fund; and
(ii)    Subject to paragraph (2) of this subsection, set fees in an amount necessary to provide revenues for the purposes of the Compassionate Use Fund.
(2)    The Commission may not impose the fees established under paragraph (1)(ii) of this subsection on a licensed medical cannabis grower, processor, or dispensary during the 2 years immediately following the issuance of a license under this subtitle.
(d)    The purpose of the Compassionate Use Fund is to provide access to medical cannabis for individuals enrolled in the Maryland Medical Assistance Program or in the Veterans Affairs Maryland Health Care System.
(e)    (1)    The Compassionate Use Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)    The State Treasurer shall hold the Compassionate Use Fund separately, and the Comptroller shall account for the Compassionate Use Fund.
(3)    The Compassionate Use Fund shall be invested and reinvested in the same manner as other State funds, and any investment earnings shall be retained to the credit of the Compassionate Use Fund.
(4)    The Compassionate Use Fund shall be subject to an audit by the Office of Legislative Audits as provided for in § 2–1220 of the State Government Article.
(5)    The Comptroller shall pay out money from the Compassionate Use Fund as directed by the Commission.
(f)    No part of the Compassionate Use Fund may revert or be credited to:
(1)    The General Fund of the State; or
(2)    Any other special fund of the State.
(g)    Expenditures from the Compassionate Use Fund may be made only in accordance with the State budget.
(h)    (1)    The Commission shall establish a program to allow eligible individuals enrolled in the Maryland Medical Assistance Program or in the Veterans Affairs Maryland Health Care System to:
(i)    Obtain medical cannabis from a licensed dispensary at a reduced cost; and
(ii)    Reimburse a licensed dispensary for the cost of the medical cannabis dispensed to an eligible individual under the program from the Compassionate Use Fund.
(2)    The Commission shall adopt regulations to implement this subsection.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3304.1 - Registration to Purchase Medical Cannabis for Purpose of Conducting Research Project Relating to Medical Uses, Properties, or Composition of Cannabis.

(a)    (1)    An institution of higher education, a related medical facility, or an affiliated biomedical research firm may file with the Commission a registration to purchase medical cannabis for the purpose of conducting a bona fide research project relating to the medical uses, properties, or composition of cannabis.
(2)    A registration filed under paragraph (1) of this subsection shall include:
(i)    The name of the primary researcher;
(ii)    The expected duration of the research; and
(iii)    The primary objectives of the research.
(3)    A registration filed under paragraph (1) of this subsection shall remain valid until there is a change in the research project or a withdrawal of the registration.
(b)    An academic research representative may purchase medical cannabis from a licensed dispensary.
(c)    An academic research representative may not be penalized or arrested under State law for acquiring, possessing, or dispensing cannabis, products containing cannabis, related supplies, or educational materials for use in a bona fide research project relating to the medical uses, properties, or composition of cannabis.
(d)    The Commission may adopt regulations to implement this section.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3305 - Reports by Commission.

On or before January 1 each year, the Commission shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on:
(1)    Providers certified under this subtitle; and
(2)    The amount sold, by condition treated, and average consumer price for medical cannabis products provided in accordance with this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3305.1 - Individuals Prohibited From Ownership.

(a)    In this section, “owner” includes any type of owner or beneficiary of a business entity, including an officer, a director, a principal employee, a partner, an investor, a stockholder, or a beneficial owner of the business entity and, notwithstanding any other provision of this subtitle, a person having any ownership interest regardless of the percentage of ownership interest.
(b)    Except as provided in subsection (c) of this section, a constitutional officer or a secretary of a principal department of the Executive Branch of the State government may not:
(1)    Be an owner or an employee of any business entity that holds a license under this subtitle; or
(2)    Have an official relationship to a business entity that holds a license under this subtitle.
(c)    A constitutional officer or a secretary of a principal department of the Executive Branch of the State government may remain an owner or an employee of a business entity that holds a license under this subtitle if the constitutional officer or secretary was an owner or employee of the business entity before the constitutional officer’s election or appointment or the secretary’s appointment.
(d)    A former member of the General Assembly, for the 1–year period immediately after the member leaves office, may not:
(1)    Be an owner or an employee of any business entity that holds a license under this subtitle; or
(2)    Have an official relationship with a business entity that holds a license under this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3305.2 - Study of Market With Respect to Assistance of Minorities and Women in Medical Cannabis Industry.

(a)    The Commission, in consultation with the certification agency as defined in § 14–301 of the State Finance and Procurement Article, the Governor’s Office of Small, Minority, and Women Business Affairs, and the Office of the Attorney General, shall:
(1)    Evaluate a study of the medical cannabis industry and market to determine whether there is a compelling interest to implement remedial measures, including the application of the State Minority Business Enterprise Program under Title 14, Subtitle 3 of the State Finance and Procurement Article or a similar program, to assist minorities and women in the medical cannabis industry;
(2)    Evaluate race–neutral programs or other methods that may be used to address the needs of minority and women applicants and minority and women–owned businesses seeking to participate in the medical cannabis industry; and
(3)    Submit emergency regulations, in accordance with Title 10, Subtitle 1 of the State Government Article, to implement remedial measures, if necessary and to the extent permitted by State and federal law, based on the findings of the study evaluated under item (1) of this subsection.
(b)    The Commission may report to the General Assembly, in accordance with § 2–1257 of the State Government Article, any information that the Commission determines to be necessary to the consideration, development, or implementation of any remedial measures required under this section.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3305.3 - Required Affidavit to Be Submitted With Licensing Application.

A person that applies for licensure under this subtitle shall submit with the application for licensure an affidavit attesting to:
(1)    The number of minority and women owners of the applicant;
(2)    The ownership interest of any minority and women owners of the applicant;
(3)    The number of minority and women employees of the applicant; and
(4)    Any other information considered necessary by the Commission.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3308 - Dispensary Agents.

(a)    A dispensary agent shall:
(1)    Be at least 21 years old;
(2)    Be registered with the Commission before the agent may volunteer or work for a dispensary; and
(3)    Obtain a State and national criminal history records check in accordance with § 13–3312 of this subtitle.
(b)    A dispensary shall apply to the Commission for a registration card for each dispensary agent by submitting the name, address, and date of birth of the agent.
(c)    (1)    Within 1 business day after a dispensary agent ceases to be associated with a dispensary, the dispensary shall:
(i)    Notify the Commission; and
(ii)    Return the dispensary agent’s registration card to the Commission.
(2)    On receipt of a notice described in paragraph (1) of this subsection, the Commission shall:
(i)    Immediately revoke the registration card of the dispensary agent; and
(ii)    If the registration card was not returned to the Commission, notify the Department of State Police.
(d)    The Commission may register an individual who has been convicted of a felony drug offense as a dispensary agent unless:
(1)    Except as provided in item (2) of this subsection, the individual submitted an application under subsection (b) of this section earlier than 7 years after the individual satisfied the sentence imposed for the conviction, including parole, probation, or mandatory supervision;
(2)    The individual has been convicted of a violation of § 5–612 or § 5–613 of the Criminal Law Article, regardless of whether the individual has satisfactorily completed the sentence for the offense; or
(3)    The Commission finds a substantial reason to deny the registration.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3310 - Processor Agents.

(a)    A processor agent shall:
(1)    Be at least 21 years old;
(2)    Be registered with the Commission before the agent may volunteer or work for a processor; and
(3)    Obtain a State and national criminal history records check in accordance with § 13–3312 of this subtitle.
(b)    A processor shall apply to the Commission for a registration card for each processor agent by submitting the name, address, and date of birth of the agent.
(c)    (1)    Within 1 business day after a processor agent ceases to be associated with a processor, the processor shall:
(i)    Notify the Commission; and
(ii)    Return the processor agent’s registration card to the Commission.
(2)    On receipt of a notice described in paragraph (1) of this subsection, the Commission shall:
(i)    Immediately revoke the registration card of the processor agent; and
(ii)    If the registration card was not returned to the Commission, notify the Department of State Police.
(d)    The Commission may register an individual who has been convicted of a felony drug offense as a processor agent unless:
(1)    Except as provided in item (2) of this subsection, the individual submitted an application under subsection (b) of this section earlier than 7 years after the individual satisfied the sentence imposed for the conviction, including parole, probation, or mandatory supervision;
(2)    The individual has been convicted of a violation of § 5–612 or § 5–613 of the Criminal Law Article, regardless of whether the individual has satisfactorily completed the sentence for the offense; or
(3)    The Commission finds a substantial reason to deny the registration.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3311 - Independent Testing Laboratory.

(a)    The Commission shall register at least one private independent testing laboratory to test cannabis and products containing cannabis that are to be sold in the State.
(b)    To be registered as an independent testing laboratory, a laboratory shall:
(1)    Meet the application requirements established by the Commission;
(2)    Pay any applicable fee required by the Commission; and
(3)    Meet the standards and requirements for accreditation, inspection, and testing established by the Commission.
(c)    The Commission shall adopt regulations that establish:
(1)    The standards and requirements to be met by an independent laboratory to obtain a registration;
(2)    The standards of care to be followed by an independent testing laboratory;
(3)    The initial and renewal terms for an independent laboratory registration and the renewal procedure; and
(4)    The bases and processes for denial, revocation, and suspension of a registration of an independent testing laboratory.
(d)    The Commission may inspect an independent testing laboratory registered under this section to ensure compliance with this subtitle.
2023 Maryland Statutes › Health - General › Title 13 - Miscellaneous Health Care Programs › Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission. [Repealed] › Section 13-3311.1 - Sale or Transfer of Ownership in License; Rescission of Stage One Preapproval; Exceptions.

(a)    (1)    The holder of a medical cannabis grower, processor, or dispensary license may sell or transfer ownership of the license if the licensee was physically and actively engaged in the cultivation, processing, or dispensing of medical cannabis for at least 3 years immediately preceding the sale or transfer of the ownership of the license.
(2)    Nothing in paragraph (1) of this subsection may be construed to limit the ability of the Commission to enforce this subtitle.
(b)    (1)    Subject to paragraph (2) of this subsection, the Commission may rescind the Stage One preapproval of an applicant if the facility of the applicant is not operational within 12 months after issuance of the Stage One preapproval due to a lack of a good faith effort by the applicant to become operational.
(2)    If the applicant can demonstrate to the Commission that the failure to become operational under paragraph (1) of this subsection was due to unforeseen hardship beyond the control of the applicant, the Commission may extend the time frame to become operational for an additional 12 months before rescinding the Stage One preapproval.